Cho BC - Search Results

1

Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma.

Kim HR, Cho BC, Shim HS, Lim SM, Kim SK, Chang J, Kim DJ, Kim JH. Kim HR, et al. Among authors: cho bc. Lung Cancer. 2014 Mar;83(3):374-82. doi: 10.1016/j.lungcan.2013.12.011. Epub 2014 Jan 3. Lung Cancer. 2014. PMID: 24468202

2

Congenital absence of inferior vena cava as a rare cause of pulmonary thromboembolism.

Cho BC, Choi HJ, Kang SM, Chang J, Lee SM, Yang DG, Hong YK, Lee DH, Lee YW, Kim SK. Cho BC, et al. Yonsei Med J. 2004 Oct 31;45(5):947-51. doi: 10.3349/ymj.2004.45.5.947. Yonsei Med J. 2004. PMID: 15515211 Free article.

3

A pilot study of trans-arterial injection of 166Holmium-Chitosan complex for treatment of small hepatocellular carcinoma.

Cho BC, Kim EH, Choi HJ, Kim JH, Roh JK, Chung HC, Ahn JB, Lee JD, Lee JT, Yoo NC, Sohn JH. Cho BC, et al. Yonsei Med J. 2005 Dec 31;46(6):799-805. doi: 10.3349/ymj.2005.46.6.799. Yonsei Med J. 2005. PMID: 16385656 Free PMC article.

4

Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.

Cho BC, Kim JH, Kim CB, Sohn JH, Choi HJ, Lee YC, Ahn JB. Cho BC, et al. Oncol Rep. 2006 Mar;15(3):621-7. Oncol Rep. 2006. PMID: 16465422 Clinical Trial.

5

A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer.

Sohn JH, Choi HJ, Chang J, Kim SK, Lee CG, Chung KY, Kim DJ, Cho BC, Shin SJ, Moon YW, Kim JH. Sohn JH, et al. Among authors: cho bc. Lung Cancer. 2006 Dec;54(3):365-70. doi: 10.1016/j.lungcan.2006.08.014. Epub 2006 Sep 29. Lung Cancer. 2006. PMID: 17011068 Clinical Trial.

6

Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy.

Choi HJ, Cho BC, Shin SJ, Cheon SH, Jung JY, Chang J, Kim SK, Sohn JH, Kim JH. Choi HJ, et al. Among authors: cho bc. Cancer Chemother Pharmacol. 2008 Feb;61(2):309-13. doi: 10.1007/s00280-007-0505-9. Epub 2007 Jun 19. Cancer Chemother Pharmacol. 2008. PMID: 17576560

7

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.

Cho BC, Im CK, Park MS, Kim SK, Chang J, Park JP, Choi HJ, Kim YJ, Shin SJ, Sohn JH, Kim H, Kim JH. Cho BC, et al. J Clin Oncol. 2007 Jun 20;25(18):2528-33. doi: 10.1200/JCO.2006.10.4166. J Clin Oncol. 2007. PMID: 17577030 Clinical Trial.

8

The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC.

Kim SH, Cho BC, Choi HJ, Chung KY, Kim DJ, Park MS, Kim SK, Chang J, Shin SJ, Sohn JH, Kim JH. Kim SH, et al. Among authors: cho bc. Lung Cancer. 2008 Jun;60(3):393-400. doi: 10.1016/j.lungcan.2007.11.004. Epub 2007 Dec 26. Lung Cancer. 2008. PMID: 18155802

9

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients.

Cho BC, Ahn JB, Seong J, Roh JK, Kim JH, Chung HC, Sohn JH, Kim NK. Cho BC, et al. BMC Cancer. 2008 Jan 15;8:8. doi: 10.1186/1471-2407-8-8. BMC Cancer. 2008. PMID: 18194582 Free PMC article. Clinical Trial.

10

A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.

Kim BK, Cho BC, Choi HJ, Sohn JH, Park MS, Chang J, Kim SK, Kim DJ, Chung KY, Lee CG, Kim JH, Yoo NC. Kim BK, et al. Among authors: cho bc. Oncol Rep. 2008 Jun;19(6):1525-31. Oncol Rep. 2008. PMID: 18497960 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

764 results

Search Page

Filters